Based on the analysis of Chemed Corp's profitability, liquidity, and operating efficiency, Chemed Corp is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in January. At present, Chemed Corp's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1.2 B, whereas Total Current Liabilities is forecasted to decline to about 167.5 M. Key indicators impacting Chemed Corp's financial strength include:
Investors should never underestimate Chemed Corp's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Chemed Corp's cash flow, debt, and profitability to make informed and accurate decisions about investing in Chemed Corp.
Cash And Equivalents
48.26 Million
Chemed
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Dividends Paid
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Account Receivables
Total Cashflows From Investing Activities
Other Cashflows From Investing Activities
Change Receivables
Net Borrowings
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Liabilities
Change To Operating Activities
Investments
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Accounts Payable
Common Stock Total Equity
Common Stock
Other Liab
Other Assets
Long Term Debt
Treasury Stock
Property Plant Equipment
Current Deferred Revenue
Net Tangible Assets
Retained Earnings Total Equity
Long Term Debt Total
Capital Surpluse
Deferred Long Term Liab
Non Current Liabilities Other
Short Long Term Debt
Cash And Equivalents
Net Invested Capital
Long Term Investments
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Net Income Applicable To Common Shares
Net Income From Continuing Ops
Non Operating Income Net Other
Selling And Marketing Expenses
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Chemed Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chemed Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Chemed Corp's assets may result in an increase in income on the income statement.
Please note, the presentation of Chemed Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemed Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemed Corp's management manipulating its earnings.
Chemed Corp Stock Summary
Chemed Corp competes with Encompass Health, Pennant, Acadia Healthcare, Select Medical, and Addus HomeCare. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Chemed operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 14137 people.
Comparative valuation techniques use various fundamental indicators to help in determining Chemed Corp's current stock value. Our valuation model uses many indicators to compare Chemed Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemed Corp competition to find correlations between indicators driving Chemed Corp's intrinsic value. More Info.
Chemed Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Chemed Corp is roughly 1.92 . At present, Chemed Corp's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Chemed Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Chemed Corp Systematic Risk
Chemed Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chemed Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Chemed Corp correlated with the market. If Beta is less than 0 Chemed Corp generally moves in the opposite direction as compared to the market. If Chemed Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chemed Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chemed Corp is generally in the same direction as the market. If Beta > 1 Chemed Corp moves generally in the same direction as, but more than the movement of the benchmark.
Chemed Corp Thematic Clasifications
Chemed Corp is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Chemed Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemed Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Chemed Corp growth as a starting point in their analysis.
Price Earnings To Growth Ratio
4.08
At present, Chemed Corp's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Chemed Corp December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chemed Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chemed Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chemed Corp based on widely used predictive technical indicators. In general, we focus on analyzing Chemed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chemed Corp's daily price indicators and compare them against related drivers.
When running Chemed Corp's price analysis, check to measure Chemed Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed Corp is operating at the current time. Most of Chemed Corp's value examination focuses on studying past and present price action to predict the probability of Chemed Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed Corp's price. Additionally, you may evaluate how the addition of Chemed Corp to your portfolios can decrease your overall portfolio volatility.